Literature DB >> 36219347

The role of the gut microbiota in health and cardiovascular diseases.

Lu Wang1,2, Shiqi Wang1,2, Qing Zhang1,2, Chengqi He1,2, Chenying Fu3,4, Quan Wei5,6.   

Abstract

The gut microbiota is critical to human health, such as digesting nutrients, forming the intestinal epithelial barrier, regulating immune function, producing vitamins and hormones, and producing metabolites to interact with the host. Meanwhile, increasing evidence indicates that the gut microbiota has a strong correlation with the occurrence, progression and treatment of cardiovascular diseases (CVDs). In patients with CVDs and corresponding risk factors, the composition and ratio of gut microbiota have significant differences compared with their healthy counterparts. Therefore, gut microbiota dysbiosis, gut microbiota-generated metabolites, and the related signaling pathway may serve as explanations for some of the mechanisms about the occurrence and development of CVDs. Several studies have also demonstrated that many traditional and latest therapeutic treatments of CVDs are associated with the gut microbiota and its generated metabolites and related signaling pathways. Given that information, we summarized the latest advances in the current research regarding the effect of gut microbiota on health, the main cardiovascular risk factors, and CVDs, highlighted the roles and mechanisms of several metabolites, and introduced corresponding promising treatments for CVDs regarding the gut microbiota. Therefore, this review mainly focuses on exploring the role of gut microbiota related metabolites and their therapeutic potential in CVDs, which may eventually provide better solutions in the development of therapeutic treatment as well as the prevention of CVDs.
© 2022. The Author(s).

Entities:  

Keywords:  Cardiovascular Diseases; Dysbiosis; Gut microbiota; Health; Metabolites; Risk factors

Year:  2022        PMID: 36219347      PMCID: PMC9554112          DOI: 10.1186/s43556-022-00091-2

Source DB:  PubMed          Journal:  Mol Biomed        ISSN: 2662-8651


  611 in total

1.  Postprandial plasma bile acid responses in normal weight and obese subjects.

Authors:  C Glicksman; D J Pournaras; M Wright; R Roberts; D Mahon; R Welbourn; R Sherwood; J Alaghband-Zadeh; C W le Roux
Journal:  Ann Clin Biochem       Date:  2010-07-01       Impact factor: 2.057

2.  Gastrointestinal hormones and the dialogue between gut and brain.

Authors:  Graham J Dockray
Journal:  J Physiol       Date:  2014-02-24       Impact factor: 5.182

3.  Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice.

Authors:  Ling Zhang; Jianfeng Du; Naohiro Yano; Hao Wang; Yu Tina Zhao; Patrycja M Dubielecka; Shougang Zhuang; Y Eugene Chin; Gangjian Qin; Ting C Zhao
Journal:  J Cell Biochem       Date:  2017-04-25       Impact factor: 4.429

4.  Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice.

Authors:  Boran Zhu; Yi Zhai; Mengjiao Ji; Yanan Wei; Jiafei Wu; Wenda Xue; Wei Wei Tao; Haoxin Wu
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

5.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

6.  Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-/- mice.

Authors:  Paul M Ryan; Lis E E London; Trent C Bjorndahl; Rupasri Mandal; Kiera Murphy; Gerald F Fitzgerald; Fergus Shanahan; R Paul Ross; David S Wishart; Noel M Caplice; Catherine Stanton
Journal:  Microbiome       Date:  2017-03-13       Impact factor: 14.650

7.  Caprylic acid suppresses inflammation via TLR4/NF-κB signaling and improves atherosclerosis in ApoE-deficient mice.

Authors:  Xinsheng Zhang; Changyong Xue; Qing Xu; Yong Zhang; Huizi Li; Feng Li; Yinghua Liu; Changjiang Guo
Journal:  Nutr Metab (Lond)       Date:  2019-06-06       Impact factor: 4.169

8.  Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism.

Authors:  Lin Ding; Mengru Chang; Ying Guo; Lingyu Zhang; Changhu Xue; Teruyoshi Yanagita; Tiantian Zhang; Yuming Wang
Journal:  Lipids Health Dis       Date:  2018-12-19       Impact factor: 3.876

Review 9.  The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis.

Authors:  Kirk Bergstrom; Lijun Xia
Journal:  Gut Microbes       Date:  2022 Jan-Dec

10.  Transmethylamine-N-Oxide Is Associated With Diffuse Cardiac Fibrosis in People Living With HIV.

Authors:  Nalini A Colaco; Teresa S Wang; Yifei Ma; Rebecca Scherzer; Olga R Ilkayeva; Patrice Desvigne-Nickens; Eugene Braunwald; Adrian F Hernandez; Javed Butler; Svati H Shah; Sanjiv J Shah; Priscilla Y Hsue
Journal:  J Am Heart Assoc       Date:  2021-08-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.